Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Reparixin by Dompe Farmaceutici for Community Acquired Pneumonia: Likelihood of Approval
Reparixin is under clinical development by Dompe Farmaceutici and currently in Phase III for Community Acquired Pneumonia. According to GlobalData,...